The DOI matches its Crossref record; 186 of the 186 references it cites were found in a registry or an index.
New molecular insights into the mechanisms of cholestasis
Open accessAbstract
Recent progress in basic research has enhanced our understanding of the molecular mechanisms of normal bile secretion and their alterations in cholestasis. Genetic transporter variants contribute to an entire spectrum of cholestatic liver diseases and can cause hereditary cholestatic syndromes or determine susceptibility and disease progression in acquired cholestatic disorders. Cholestasis is associated with complex transcriptional and post-transcriptional alterations of hepatobiliary transporters and enzymes participating in bile formation. Ligand-activated nuclear receptors for bile acids and other biliary compounds play a key role in the regulation of genes required for bile formation. Pharmacological interventions in cholestasis may aim at modulating such novel regulatory pathways. This review will summarize the principles of molecular alterations in cholestasis and will give an overview of potential clinical implications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis
Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C. L., McDonald, J. G., Luo, G., Jones, S. A., Goodwin, B., Richardson, J. A., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.001 · Cited by 1,865
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628 · cited 2×
“, Kupffer cells/macrophages) anti-inflammatory and immunosuppressive properties of bile acids may be mediated via the membrane-bound G-protein-coupled bile acid receptor TGR5/Tgr5 [163,164].”
BackgroundMolecular Basis for Feedback Regulation of Bile Acid Synthesis by Nuclear Receptors
Lu, T. T., Makishima, M., Repa, J. J., Schoonjans, K., Kerr, T. A., Auwerx, J., & Mangelsdorf, D. J. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00050-2 · Cited by 1,487
Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor
Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · cited 3×
“Conversely, absence of bile leads to bacterial overgrowth, mucosal injury, bacterial translocation and endotoxinemia in the small intestine [138,139].”
BackgroundBile salt transporters: molecular characterization, function, and regulation
Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999
Self-citationStrautnieks, S. S., Bull, L. N., Knisely, A. S., Kocoshis, S. A., Dahl, N., Arnell, H., Sokal, E., Dahan, K., Childs, S., Ling, V., et al. (1998) · Nature Genetics · doi:10.1038/3034 · Cited by 995
The Continuing Importance of Bile Acids in Liver and Intestinal Disease
Hofmann, A. F. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.22.2647 · Cited by 982
Kast, H. R., Goodwin, B., Tarr, P. T., Jones, S. A., Anisfeld, A. M., Stoltz, C. M., Tontonoz, P., Kliewer, S., Willson, T. M., & Edwards, P. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109326200 · Cited by 916 · cited 14×
“The best defined nuclear receptor for bile acids, farnesoid X receptor (FXR, NR1H4), is critically involved in the regulation of Na-dependent (NTCP) and Na-independent hepatocellular bile acid uptake (OATP1B1 and OATP1B3) [19,20], canalicular excretion of monovalent (BSEP) [21] and divalent bile acids (MRP2), conjugat…”
BackgroundInfluentialAnanthanarayanan, M., Balasubramanian, N., Makishima, M., Mangelsdorf, D. J., & Suchy, F. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011610200 · Cited by 801
Parés, A., Caballería, L., & Rodés, J. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.029 · Cited by 756 · cited 1×
“However, in prototypic cholestatic liver diseases such as PBC, up to one to two third of patients only incompletely respond to UDCA and remain at continued increased risk for disease progression to cirrhosis and potential need for liver transplantation [174,175].”
BackgroundA gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis
Bull, L. N., van Eijk, M. J. T., Pawlikowska, L., DeYoung, J. A., Juijn, J. A., Liao, M., Klomp, L. W. J., Lomri, N., Berger, R., Scharschmidt, B. R., et al. (1998) · Nature Genetics · doi:10.1038/ng0398-219 · Cited by 736
Mutations in the MDR 3 gene cause progressive familial intrahepatic cholestasis
de Vree, J. M. L., Jacquemin, E., Sturm, E., Cresteil, D., Bosma, P. J., Aten, J., Deleuze, J.-F., Desrochers, M., Burdelski, M., Bernard, O., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.282 · Cited by 735
Kullak-Ublick, G. A., Ismair, M. G., Stieger, B., Landmann, L., Huber, R., Pizzagalli, F., Fattinger, K., Meier, P. J., & Hagenbuch, B. (2001) · Gastroenterology · doi:10.1053/gast.2001.21176 · Cited by 723
Molecular Pathogenesis of Cholestasis
Trauner, M., Meier, P. J., & Boyer, J. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391707 · Cited by 706
Self-citationEnterohepatic bile salt transporters in normal physiology and liver disease
Kullak-ublick, G. A., Stieger, B., & Meier, P. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.06.005 · Cited by 658
Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
Corpechot, C., Abenavoli, L., Rabahi, N., Chrétien, Y., Andréani, T., Johanet, C., Chazouillères, O., & Poupon, R. (2008) · Hepatology · doi:10.1002/hep.22428 · Cited by 646 · cited 1×
“However, in prototypic cholestatic liver diseases such as PBC, up to one to two third of patients only incompletely respond to UDCA and remain at continued increased risk for disease progression to cirrhosis and potential need for liver transplantation [174,175].”
BackgroundFarnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response
Wang, Y.-D., Chen, W.-D., Wang, M., Yu, D., Forman, B. M., & Huang, W. (2008) · Hepatology · doi:10.1002/hep.22519 · Cited by 639 · cited 3×
“Pro-inflammatory cytokines are potent inhibitors of hepatobiliary transport and NR expression and function [2,145,146].”
BackgroundBile acids as carcinogens in human gastrointestinal cancers
Bernstein, H., Bernstein, C., Payne, C. M., Dvorakova, K., & Garewal, H. (2005) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2004.08.001 · Cited by 611
Molecular Pathogenesis of Cholestasis
Trauner, M., & Jansen, P. L. M. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9034-1 · Cited by 610
Self-citationUrsodiol for Primary Sclerosing Cholangitis
Lindor, K. D. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703063361003 · Cited by 598
Stieger, B., Fattinger, K., Madon, J., Kullak-Ublick, G. A., & Meier, P. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70224-1 · Cited by 582
Paulusma, C. C., Kool, M., Bosma, P. J., Scheffer, G. L., ter Borg, F., Scheper, R. J., Tytgat, G. N., Borst, P., Baas, F., & Elferink, R. O. (1997) · Hepatology · doi:10.1002/hep.510250635 · Cited by 552
Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management
Lammert, F., Marschall, H.-U., Glantz, A., & Matern, S. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80139-7 · Cited by 524
Jacquemin, E., Bernard, O., Hadchouel, M., Cresteil, D., De Vree, J. M. L., Paul, M., Elferink, R. P. J. O., Bosma, P. J., Sokal, E. M., Sturm, E., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.23984 · Cited by 523
Fattinger, K. (2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.114667 · Cited by 509
Trauner, M., Arrese, M., Soroka, C., Ananthanarayanan, M., Koeppel, T., Schlosser, S., Suchy, F., Keppler, D., & Boyer, J. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70103-3 · Cited by 500
Self-citationProgressive familial intrahepatic cholestasis
Davit-Spraul, A., Gonzales, E., Baussan, C., & Jacquemin, E. (2009) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-4-1 · Cited by 482
Fickert, P., Fuchsbichler, A., Wagner, M., Zollner, G., Kaser, A., Tilg, H., Krause, R., Lammert, F., Langner, C., Zatloukal, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.009 · Cited by 468
Self-citationDenson, L. A., Sturm, E., Echevarria, W., Zimmerman, T. L., Makishima, M., Mangelsdorf, D. J., & Karpen, S. J. (2001) · Gastroenterology · doi:10.1053/gast.2001.25503 · Cited by 460
Hadj-Rabia, S., Baala, L., Vabres, P., Hamel-Teillac, D., Jacquemin, E., Fabre, M., Lyonnet, S., de Prost, Y., Munnich, A., Hadchouel, M., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.07.022 · Cited by 428
Expression and function of the bile acid receptor TGR5 in Kupffer cells
Keitel, V., Donner, M., Winandy, S., Kubitz, R., & Häussinger, D. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.171 · Cited by 418
Drug Insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis
Beuers, U. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0521 · Cited by 417 · cited 1×
“, MRP3, MRP4) for adaptive alternative excretion of bile acids back from hepatocytes into the systemic circulation [111,170–173].”
BackgroundMechanisms and regulation of bile secretion
Nathanson, M. H., & Boyer, J. L. (1991) · Hepatology · doi:10.1002/hep.1840140324 · Cited by 406
Zhou, C. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26283 · Cited by 402
Liu, Y., Binz, J., Numerick, M. J., Dennis, S., Luo, G., Desai, B., MacKenzie, K. I., Mansfield, T. A., Kliewer, S. A., Goodwin, B., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18945 · Cited by 398
Knisely, A. S., Strautnieks, S. S., Meier, Y., Stieger, B., Byrne, J. A., Portmann, B. C., Bull, L. N., Pawlikowska, L., Bilezikçi, B., Özçay, F., et al. (2006) · Hepatology · doi:10.1002/hep.21287 · Cited by 379
The cholangiopathies: Disorders of biliary epithelia
Lazaridis, K. N., Strazzabosco, M., & LaRusso, N. F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.006 · Cited by 372
Zollner, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22646 · Cited by 362
Self-citationWagner, M., Halilbasic, E., Marschall, H., Zollner, G., Fickert, P., Langner, C., Zatloukal, K., Denk, H., & Trauner, M. (2005) · Hepatology · doi:10.1002/hep.20784 · Cited by 355 · cited 1×
“Pxr and Car agonists induce these basolateral overflow system Mrp3 and Mrp4 together with phase I and phase II detoxification enzymes, thereby lowering biochemical markers of cholestasis [124].”
BackgroundSelf-citationBenign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11
van Mil, S. W. C., van der Woerd, W. L., van der Brugge, G., Sturm, E., Jansen, P. L. M., Bull, L. N., van den Berg, I. E. T., Berger, R., Houwen, R. H. J., & Klomp, L. W. J. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.065 · Cited by 345
Lang, C., Meier, Y., Stieger, B., Beuers, U., Lang, T., Kerb, R., Kullak-Ublick, G. A., Meier, P. J., & Pauli-Magnus, C. (2007) · Pharmacogenetics and Genomics · doi:10.1097/01.fpc.0000230418.28091.76 · Cited by 339
Zollner, G., Marschall, H.-U., Wagner, M., & Trauner, M. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060010s · Cited by 335
Self-citationComplex inheritance of familial hypercholanemia with associated mutations in TJP2 and BAAT
Carlton, V. E. H., Harris, B. Z., Puffenberger, E. G., Batta, A. K., Knisely, A. S., Robinson, D. L., Strauss, K. A., Shneider, B. L., Lim, W. A., Salen, G., et al. (2003) · Nature Genetics · doi:10.1038/ng1147 · Cited by 329
Prevention of cholesterol gallstone disease by FXR agonists in a mouse model
Moschetta, A., Bookout, A. L., & Mangelsdorf, D. J. (2004) · Nature Medicine · doi:10.1038/nm1138 · Cited by 325
MARSCHALL, H., WAGNER, M., ZOLLNER, G., FICKERT, P., DICZFALUSY, U., GUMHOLD, J., SILBERT, D., FUCHSBICHLER, A., BENTHIN, L., & GRUNDSTROM, R. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.009 · Cited by 325
Self-citationThe enterohepatic circulation of bile acids in mammals: form and functions
Hofmann, A. (2009) · Frontiers in Bioscience · doi:10.2741/3399 · Cited by 322
Lorenzo-Zúñiga, V., Bartolí, R., Planas, R., Hofmann, A. F., Viñado, B., Hagey, L. R., Hernández, J. M., Mañé, J., Alvarez, M. A., Ausina, V., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50116 · Cited by 321
Maher, J. M., Dieter, M. Z., Aleksunes, L. M., Slitt, A. L., Guo, G., Tanaka, Y., Scheffer, G. L., Chan, J. Y., Manautou, J. E., Chen, Y., et al. (2007) · Hepatology · doi:10.1002/hep.21831 · Cited by 315
Geier, A., Wagner, M., Dietrich, C. G., & Trauner, M. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.04.014 · Cited by 314
Self-citationFickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Weiglein, A. H., Lammert, F., Marschall, H., Tsybrovskyy, O., Zatloukal, K., Denk, H., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35948 · Cited by 313
Self-citationRegulation of hepatocyte bile salt transporters by endotoxin and inflammatory cytokines in rodents
Green, R., Beier, D., & Gollan, J. (1996) · Gastroenterology · doi:10.1053/gast.1996.v111.pm8698199 · Cited by 308
Boyer, J. L., Trauner, M., Mennone, A., Soroka, C. J., Cai, S.-Y., Moustafa, T., Zollner, G., Lee, J. Y., & Ballatori, N. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00539.2005 · Cited by 303
Self-citationFickert, P., Wagner, M., Marschall, H., Fuchsbichler, A., Zollner, G., Tsybrovskyy, O., Zatloukal, K., Liu, J., Waalkes, M. P., Cover, C., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.10.018 · Cited by 300
Self-citationFunk, C., Ponelle, C., Scheuermann, G., & Pantze, M. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12255-9 · Cited by 296
Hepatobiliary transporters and drug‐induced cholestasis†
Pauli‐Magnus, C., & Meier, P. J. (2006) · Hepatology · doi:10.1002/hep.21359 · Cited by 285
Schaap, F. G., van der Gaag, N. A., Gouma, D. J., & Jansen, P. L. M. (2009) · Hepatology · doi:10.1002/hep.22771 · Cited by 284
Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein)
Oude Elferink, R. P. J., & Paulusma, C. C. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0062-9 · Cited by 282
ABCB4 gene mutation-associated cholelithiasis in adults
Rosmorduc, O., Hermelin, B., Boelle, P., Parc, R., Taboury, J., & Poupon, R. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00898-9 · Cited by 282
Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis
Zollner, G., Fickert, P., Silbert, D., Fuchsbichler, A., Marschall, H.-U., Zatloukal, K., Denk, H., & Trauner, M. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00096-5 · Cited by 275
Self-citationThe causes of primary biliary cirrhosis: Convenient and inconvenient truths
Gershwin, E. M., & Mackay, I. R. (2008) · Hepatology · doi:10.1002/hep.22042 · Cited by 274
Pauli-Magnus, C., Lang, T., Meier, Y., Zodan-Marin, T., Jung, D., Breymann, C., Zimmermann, R., Kenngott, S., Beuers, U., Reichel, C., et al. (2004) · Pharmacogenetics · doi:10.1097/00008571-200402000-00003 · Cited by 273
Trauner, M., Arrese, M., Lee, H., Boyer, J. L., & Karpen, S. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1680 · Cited by 265
Self-citationWagner, M., Fickert, P., Zollner, G., Fuchsbichler, A., Silbert, D., Tsybrovskyy, O., Zatloukal, K., Guo, G. L., Schuetz, J. D., Gonzalez, F. J., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01068-0 · Cited by 264
Self-citationBolder, U., Ton-Nu, H., Schteingart, C., Frick, E., & Hofmann, A. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70238-5 · Cited by 260
van Mil, S. W. C., Milona, A., Dixon, P. H., Mullenbach, R., Geenes, V. L., Chambers, J., Shevchuk, V., Moore, G. E., Lammert, F., Glantz, A. G., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.015 · Cited by 257
Gartung, C., Ananthanarayanan, M., Rahman, M., Schuele, S., Nundy, S., Soroka, C., Stolz, A., Suchy, F., & Boyer, J. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8536857 · Cited by 255
Smith, A. J., van Helvoort, A., van Meer, G., Szabó, K., Welker, E., Szakács, G., Váradi, A., Sarkadi, B., & Borst, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909002199 · Cited by 252
Expression of the bile salt export pump is maintained after chronic cholestasis in the rat
Lee, J. M., Trauner, M., Soroka, C. J., Stieger, B., Meier, P. J., & Boyer, J. L. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70425-2 · Cited by 248
Self-citationYoon, Y. B., Hagey, L. R., Hofmann, A. F., Gurantz, D., Michelotti, E. L., & Steinbagh, J. H. (1986) · Gastroenterology · doi:10.1016/0016-5085(86)90859-0 · Cited by 248
Farnesoid X Receptor Activates Transcription of the Phospholipid Pump MDR3
Huang, L., Zhao, A., Lew, J.-L., Zhang, T., Hrywna, Y., Thompson, J. R., de Pedro, N., Royo, I., Blevins, R. A., Peláez, F., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308321200 · Cited by 248
Hepatic Secretion of Conjugated Drugs and Endogenous Substances
KEPPLER, D., & KÖNIG, J. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9391 · Cited by 245
Inflammation-induced cholestasis
Trauner, M., Fickert, P., & Stauber, R. E. (1999) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.1999.01982.x · Cited by 244
Self-citationEffects of long-term rifampicin administration in primary biliary cirrhosis
Bachs, L., Parés, A., Elena, M., Piera, C., & Rodés, J. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90335-v · Cited by 235
Paulusma, C. C., Groen, A., Kunne, C., Ho-Mok, K. S., Spijkerboer, A. L., de Waart, R. D., Hoek, F. J., Vreeling, H., Hoeben, K. A., van Marle, J., et al. (2006) · Hepatology · doi:10.1002/hep.21212 · Cited by 234
Mechanisms of Disease: mechanisms and clinical implications of cholestasis in sepsis
Geier, A., Fickert, P., & Trauner, M. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0602 · Cited by 234
Self-citationKubitz, R., Wettstein, M., Warskulat, U., & Häussinger, D. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70138-1 · Cited by 228
Endotoxin-induced cytokine gene expression and excretion in the liver
Luster, M. I., Germolec, D. R., Yoshida, T., Kayama, F., & Thompson, M. (1994) · Hepatology · doi:10.1002/hep.1840190229 · Cited by 224
Meier, Y., Pauli-Magnus, C., Zanger, U. M., Klein, K., Schaeffeler, E., Nussler, A. K., Nussler, N., Eichelbaum, M., Meier, P. J., & Stieger, B. (2006) · Hepatology · doi:10.1002/hep.21214 · Cited by 219
Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy
Dixon, P. H., van Mil, S. W. C., Chambers, J., Strautnieks, S., Thompson, R. J., Lammert, F., Kubitz, R., Keitel, V, Glantz, A., Mattsson, L.-Å., et al. (2009) · Gut · doi:10.1136/gut.2008.159541 · Cited by 215
MDR3 (ABCB4) Defects: A Paradigm for the Genetics of Adult Cholestatic Syndromes
Trauner, M., Fickert, P., & Wagner, M. (2007) · Seminars in Liver Disease · doi:10.1055/s-2006-960172 · Cited by 214
Self-citationDecreased Anion Exchanger 2 Immunoreactivity in the Liver of Patients With Primary Biliary Cirrhosis
Medina, J. F., Martínez-Ansó, E., Vázquez, J. J., & Prieto, J. (1997) · Hepatology · doi:10.1002/hep.510250104 · Cited by 207
Lucena, J.-F., Herrero, J. I., Quiroga, J., Sangro, B., Garcia-Foncillas, J., Zabalegui, N., Sola, J., Herraiz, M., Medina, J. F., & Prieto, J. (2003) · Gastroenterology · doi:10.1053/gast.2003.50144 · Cited by 198
Familial intrahepatic cholestasis 1: Studies of localization and function
Ujhazy, P., Ortiz, D., Misra, S., Li, S., Moseley, J., Jones, H., & Arias, I. M. (2001) · Hepatology · doi:10.1053/jhep.2001.27663 · Cited by 196
Salas, J. T., Banales, J. M., Sarvide, S., Recalde, S., Ferrer, A., Uriarte, I., Oude Elferink, R. P. J., Prieto, J., & Medina, J. F. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.020 · Cited by 195
Hepatocyte Nuclear Factor 1α: A Key Mediator of the Effect of Bile Acids on Gene Expression
Jung, D., & Kullak-Ublick, G. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50100 · Cited by 194
Zollner, G., Fickert, P., Fuchsbichler, A., Silbert, D., Wagner, M., Arbeiter, S., Gonzalez, F. J., Marschall, H.-U., Zatloukal, K., Denk, H., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00228-9 · Cited by 193
Self-citationBeigneux, A. P., Moser, A. H., Shigenaga, J. K., Grunfeld, C., & Feingold, K. R. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00196-1 · Cited by 192
Chen, F., Ananthanarayanan, M., Emre, S., Neimark, E., Bull, L. N., Knisely, A. S., Strautnieks, S. S., Thompson, R. J., Magid, M. S., Gordon, R., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.12.013 · Cited by 191
Denson, L. A., Auld, K. L., Schiek, D. S., McClure, M. H., Mangelsdorf, D. J., & Karpen, S. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8835 · Cited by 187
Zelcer, N., Wetering, K. V. D., Waart, R. D., Scheffer, G. L., Marschall, H.-U., Wielinga, P. R., Kuil, A., Kunne, C., Smith, A., Valk, M. V. D., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.07.022 · Cited by 181
Pauli-Magnus, C., Kerb, R., Fattinger, K., Lang, T., Anwald, B., Kullak-Ublick, G. A., Beuers, U., & Meier, P. J. (2004) · Hepatology · doi:10.1002/hep.20159 · Cited by 181
LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process
Elferink, M. G. L., Olinga, P., Draaisma, A. L., Merema, M. T., Faber, K. N., Slooff, M. J. H., Meijer, D. K. F., & Groothuis, G. M. M. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00071.2004 · Cited by 180
Mrp4−/− mice have an impaired cytoprotective response in obstructive cholestasis
Mennone, A., Soroka, C. J., Cai, S.-Y., Harry, K., Adachi, M., Hagey, L., Schuetz, J. D., & Boyer, J. L. (2006) · Hepatology · doi:10.1002/hep.21158 · Cited by 179
Pathophysiology of Cholangiopathies
Strazzabosco, M., Fabris, L., & Spirli, C. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000155549.29643.ad · Cited by 178
Enterohepatic transport of bile salts and genetics of cholestasis
Pauli-Magnus, C., Stieger, B., Meier, Y., Kullak-Ublick, G. A., & Meier, P. J. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.03.017 · Cited by 175
Lykavieris, P., van Mil, S., Cresteil, D., Fabre, M., Hadchouel, M., Klomp, L., Bernard, O., & Jacquemin, E. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00286-1 · Cited by 175
Low phospholipid associated cholelithiasis: association with mutation in the MDR3/ABCB4 gene
Rosmorduc, O., & Poupon, R. (2007) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-2-29 · Cited by 175
ABCB4 Heterozygous Gene Mutations Associated With Fibrosing Cholestatic Liver Disease in Adults
Ziol, M., Barbu, V., Rosmorduc, O., Frassati–Biaggi, A., Barget, N., Hermelin, B., Scheffer, G. L., Bennouna, S., Trinchet, J., Beaugrand, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.044 · Cited by 174
The Involvement of the Pregnane X Receptor in Hepatic Gene Regulation during Inflammation in Mice
Teng, S., & Piquette-Miller, M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076141 · Cited by 173
Jacquemin, E. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-19033 · Cited by 171
Jung, D., Podvinec, M., Meyer, U. A., Mangelsdorf, D. J., Fried, M., Meier, P. J., & Kullak–Ublick, G. A. (2002) · Gastroenterology · doi:10.1053/gast.2002.33583 · Cited by 170
Benefit of farnesoid X receptor inhibition in obstructive cholestasis
Stedman, C., Liddle, C., Coulter, S., Sonoda, J., Alvarez, J. G., Evans, R. M., & Downes, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604772103 · Cited by 170
Repression of Farnesoid X Receptor during the Acute Phase Response
Kim, M. S., Shigenaga, J. K., Moser, A., Feingold, K. R., & Grünfeld, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212633200 · Cited by 166
Meier, Y., Zodan, T., Lang, C., Zimmermann, R., Kullak-Ublick, G. A., Meier, P. J., Stieger, B., & Pauli-Magnus, C. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.38 · Cited by 165
Trauner, M., Wagner, M., Fickert, P., & Zollner, G. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000155551.37266.26 · Cited by 164
Self-citationHepatocanalicular Transport Defects: Pathophysiologic Mechanisms of Rare Diseases
Elferink, R. P. J. O., Paulusma, C. C., & Groen, A. K. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.08.052 · Cited by 163
Absence of the SRC-2 Coactivator Results in a Glycogenopathy Resembling Von Gierke's Disease
Chopra, A. R., Louet, J.-F., Saha, P., An, J., DeMayo, F., Xu, J., York, B., Karpen, S., Finegold, M., Moore, D., et al. (2008) · Science · doi:10.1126/science.1164847 · Cited by 161
KOK, T., BLOKS, V. W., WOLTERS, H., HAVINGA, R., JANSEN, P. L. M., STAELS, B., & KUIPERS, F. (2003) · Biochemical Journal · doi:10.1042/bj20020981 · Cited by 160
Keitel, V., Vogt, C., Häussinger, D., & Kubitz, R. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.003 · Cited by 159
Halilbasic, E., Fiorotto, R., Fickert, P., Marschall, H., Moustafa, T., Spirlı̀, C., Fuchsbichler, A., Gumhold, J., Silbert, D., Zatloukal, K., et al. (2009) · Hepatology · doi:10.1002/hep.22891 · Cited by 157
Self-citationEtiopathogenesis of Primary Sclerosing Cholangitis
O'Mahony, C. A., & Vierling, J. M. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-933559 · Cited by 157
Wasmuth, H. E., Glantz, A., Keppeler, H., Simon, E., Bartz, C., Rath, W. H., La, M., Marschall, H., & Lammert, F. (2006) · Gut · doi:10.1136/gut.2006.092742 · Cited by 157
Ooteghem, N. A., Klomp, L. W. J., Henegouwen, G. P. V. B., & Houwen, R. H. J. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00299-9 · Cited by 157
Moseley, R. H., Wang, W., Takeda, H., Lown, K., Shick, L., Ananthanarayanan, M., & Suchy, F. J. (1996) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1996.271.1.g137 · Cited by 157
Abnormal expression of anion exchanger genes in primary biliary cirrhosis
Prìeto, J., Qian, C., García, N., Díez, J., & Medina, J. F. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90735-u · Cited by 151
ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy
Müllenbach, R., Bennett, A., Tetlow, N., Patel, N., Hamilton, G., Cheng, F., Chambers, J., Howard, R., Taylor-Robinson, S., & Williamson, C. (2005) · Gut · doi:10.1136/gut.2004.058115 · Cited by 151
Okada, K., Shoda, J., Taguchi, K., Maher, J. M., Ishizaki, K., Inoue, Y., Ohtsuki, M., Goto, N., Takeda, K., Utsunomiya, H., et al. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90321.2008 · Cited by 149
Interleukin-1β-mediated Suppression of RXR:RAR Transactivation of the Ntcp Promoter Is JNK-dependent
Li, D., Zimmerman, T. L., Thevananther, S., Lee, H., Kurie, J. M., & Karpen, S. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204818200 · Cited by 138
Zollner, G., Wagner, M., Fickert, P., Silbert, D., Gumhold, J., Zatloukal, K., Denk, H., & Trauner, M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01506.x · Cited by 137
Self-citationAssessment of biliary bicarbonate secretion in humans by positron emission tomography
Prìeto, J., García, N., Martí-Climent, J. M., Peñuelas, I., Richter, J. Á., & Medina, J. F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70564-0 · Cited by 135
Ghose, R., Zimmerman, T. L., Thevananther, S., & Karpen, S. J. (2004) · Nuclear Receptor · doi:10.1186/1478-1336-2-4 · Cited by 135
Vallejo, M., Briz, Ó., Serrano, M. A., Monte, M. J., & Marı́n, J. J. G. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.09.017 · Cited by 134
Cellular regulation of hepatic bile acid transport in health and cholestasis
Anwer, S. M. (2004) · Hepatology · doi:10.1002/hep.20090 · Cited by 134
Frankenberg, T., Miloh, T., Chen, F. Y., Ananthanarayanan, M., Sun, A., Balasubramaniyan, N., Arias, I. M., Setchell, K. D. R., Suchy, F. J., & Shneider, B. L. (2008) · Hepatology · doi:10.1002/hep.22431 · Cited by 132
Bezafibrate treatment: a new medical approach for PBC patients?
Kanda, T., Yokosuka, O., Imazeki, F., & Saisho, H. (2003) · Journal of Gastroenterology · doi:10.1007/s00535-002-1102-7 · Cited by 129 · cited 1×
“Also agonists of peroxisome proliferator-activated receptor alpha (PPARa, NR1C1) are promising therapeutic approaches in human cholestatic liver disease since fibrates showed beneficial effects on biochemical parameters of cholestasis and/or transaminases in PBC patients with suboptimal response to UDCA [187–189].”
BackgroundGenetic factors of susceptibility and of severity in primary biliary cirrhosis
Poupon, R. Y., Chen, P., Chrétien, Y., Corpechot, C., Chazouillères, O., Simon, T., Heath, S. C., Matsuda, F., Poupon, R. E., Housset, C., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.027 · Cited by 129
Cholangiocyte Biology and Cystic Fibrosis Liver Disease
Feranchak, A. P., & Sokol, R. J. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-19030 · Cited by 127
Álvarez, L., Jara, P., Sánchez-Sabaté, E., Hierro, L., Larrauri, J., Díaz, M. C., Camarena, C., Vega, A. D. L., Frauca, E., López‐Collazo, E., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh261 · Cited by 125
Cai, S., Gautam, S., Nguyen, T., Soroka, C. J., Rahner, C., & Boyer, J. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.025 · Cited by 119
Molecular Alterations in Hepatocyte Transport Mechanisms in Acquired Cholestatic Liver Disorders
LEE, J., & Boyer, J. L. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9390 · Cited by 119
Functional Heterogeneity of Cholangiocytes
Marzioni, M., Glaser, S. S., Francis, H., Phinizy, J. L., LeSage, G., & Alpini, G. D. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-34501 · Cited by 118
Jung, D., Hagenbuch, B., Fried, M., Meier, P. J., & Kullak-Ublick, G. A. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00456.2003 · Cited by 116
Multi-modulation of nuclear receptor coactivators through posttranslational modifications
Han, S. J., Lonard, D. M., & O’Malley, B. W. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.10.001 · Cited by 114
Nakai, S., Masaki, T., Kurokohchi, K., Deguchi, A., & Nishioka, M. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01667.x · Cited by 113
Stiehl, A., Thaler, M., & Admirand, W. H. (1972) · New England Journal of Medicine · doi:10.1056/nejm197204202861602 · Cited by 113
Bile Acid inhibition of the intestinal microflora—A function for simple bile acids?
Floch, M. H., Gershengoren, W., Elliott, S., & Spiro, H. M. (1971) · Gastroenterology · doi:10.1016/s0016-5085(19)33602-9 · Cited by 113
Fang, H.-L., Strom, S. C., Cai, H., Falany, C. N., Kocarek, T. A., & Runge‐Morris, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.005389 · Cited by 112
Shoda, J., Kano, M., Oda, K., Kamiya, J., Nimura, Y., Suzuki, H., Sugiyama, Y., Miyazaki, H., Todoroki, T., Stengelin, S., et al. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.05339.x · Cited by 112
Regulation of cholesterol and bile acid homoeostasis in bile-obstructed rats
Dueland, S., Reichen, J., Everson, G. T., & Davis, R. A. (1991) · Biochemical Journal · doi:10.1042/bj2800373 · Cited by 110
Bile Salt Excretory Pump: Biology and Pathobiology
Suchy, F. J., & Ananthanarayanan, M. (2006) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/01.mpg.0000226385.71859.5f · Cited by 107
Buis, C. I., Geuken, E., Visser, D. S., Kuipers, F., Haagsma, E. B., Verkade, H. J., & Porte, R. J. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.032 · Cited by 106
Regan, M. M., Durie, P. R., Zielenski, J., Sheth, S. G., Shea, J. C., Bishop, M. D., Chopra, S., Malmberg, E., Walker, C., Ricci, R., et al. (2003) · Human Genetics · doi:10.1007/s00439-003-0963-z · Cited by 106
Assessment of Biliary Bicarbonate Secretion in Humans by Positron Emission Tomography
Prìeto, J., García, N., Martí-Climent, J. M., Peñuelas, L., Richter, J. Á., & Medina, J. F. (2017) · Revista de medicina de la Universidad de Navarra · doi:10.15581/021.6810 · Cited by 106
Geuken, E., Visser, D. S., Kuipers, F., Blokzijl, H., Leuvenink, H. G. D., de Jong, K. P., Peeters, P. M. J. G., Jansen, P. L. M., Slooff, M. J. H., Gouw, A. S. H., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.08.023 · Cited by 105
Sookoian, S. C., Castaño, G. O., Burgueño, A. L., Gianotti, T. F., & Pirola, C. J. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.08.015 · Cited by 105
Sequence variation in the ATP8B1 gene and intrahepatic cholestasis of pregnancy
Painter, J. N., Savander, M., Ropponen, A., Nupponen, N. N., Riikonen, S., Ylikorkala, O., Lehesjoki, A., & Aittomäki, K. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201355 · Cited by 100
Lang, T., Haberl, M., Jung, D., Drescher, A., Schlagenhaufer, R., Keil, A., Mornhinweg, E., Stieger, B., Kullak-Ublick, G. A., & Kerb, R. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008854 · Cited by 99
Schneider, G., Paus, T. C., Kullak-Ublick, G. A., Meier, P. J., Wienker, T. F., Lang, T., de Vondel, P. V., Sauerbruch, T., & Reichel, C. (2006) · Hepatology · doi:10.1002/hep.21500 · Cited by 98
Expression of hepatic transporters OATP‐C and MRP2 in primary sclerosing cholangitis
Oswald, M., Kullak-Ublick, G. A., Paumgartner, G., & Beuers, U. H. (2001) · Liver International · doi:10.1034/j.1600-0676.2001.021004247.x · Cited by 98
Zollner, G., Wagner, M., Fickert, P., Geier, A., Fuchsbichler, A., Silbert, D., Gumhold, J., Zatloukal, K., Kaser, A., Tilg, H., et al. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00319.2004 · Cited by 97
Self-citationSimvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers
Ritzel, U., Leonhardt, U., Näther, M., Schäfer, G., Armstrong, V. W., & Ramadori, G. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00006-5 · Cited by 94
PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
Jacquemin, E. (2000) · Clinics in Liver Disease · doi:10.1016/s1089-3261(05)70139-2 · Cited by 92
Jansen, P. L. M., Müller, M. M., & Sturm, E. (2001) · Hepatology · doi:10.1053/jhep.2001.29625 · Cited by 88
Kovacs, P. L., Kress, R., Rocha, J., Kurtz, U., Miquel, J. F., Nervi, F. O., Méndez‐Sánchez, N., Uribe, M., Bock, H. H., Schirin-Sokhan, R., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.027 · Cited by 84
Regulation of Transporters by Nuclear Hormone Receptors: Implications during Inflammation
Teng, S., & Piquette‐Miller, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700102q · Cited by 81
Induction of colitis in cftr−/− mice results in bile duct injury
Blanco, P. G., Zaman, M. M., Junaidi, O., Sheth, S. G., Yantiss, R. K., Nasser, I. A., & Freedman, S. D. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00452.2003 · Cited by 79
Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice
Zollner, G., Fickert, P., Silbert, D., Fuchsbichler, A., Stumptner, C., Zatloukal, K., Denk, H., & Trauner, M. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00215.2001 · Cited by 79
Self-citationKarlsen, T. H., Lie, B. A., Frøslie, K. F., Thorsby, E., Broomé, U., Schrumpf, E., & Boberg, K. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.057 · Cited by 75
Nuclear Receptor Ligands: Rational and Effective Therapy for Chronic Cholestatic Liver Disease?
Boyer, J. L. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.06.053 · Cited by 74
Pandak, W. M., Heuman, D. M., Hylemon, P. B., Chiang, J. Y. L., & Vlahčevič, Z. R. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90083-7 · Cited by 71
The Medical Management of Primary Sclerosing Cholangitis
Cullen, S. N., & Chapman, R. W. (2006) · Seminars in Liver Disease · doi:10.1055/s-2006-933563 · Cited by 70
Intrahepatic cholestasis of pregnancy: three novel MDR3 gene mutations
Floreani, A., Carderi, I., Paternoster, D. M., Soardo, G., Azzaroli, F., Esposito, W., Variola, A., Tommasi, A. M., Marchesoni, D., Braghin, C., et al. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02869.x · Cited by 70
Park, Y. J., Qatanani, M., Chua, S. S., LaRey, J. L., Johnson, S. A., Watanabe, M., Moore, D. D., & Lee, Y. K. (2008) · Hepatology · doi:10.1002/hep.22196 · Cited by 68 · cited 1×
“In contrast, CBDL in Shp knockout mice results in downregulation of Ntcp, suggesting that Shp-independent mechanisms might also be involved [117].”
BackgroundHoekstra, H., Porte, R. J., Tian, Y., Jochum, W., Stieger, B., Moritz, W., Slooff, M. J. H., Graf, R., & Clavien, P. (2006) · Hepatology · doi:10.1002/hep.21169 · Cited by 63
Regulation of cholangiocyte bile secretion
Baiocchi, L., LeSage, G., Glaser, S. S., & Alpini, G. D. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80180-9 · Cited by 62
Hooiveld, G. J. E. J., Vos, T. A., Scheffer, G. L., van Goor, H., Koning, H., Bloks, V. W., Loot, A. E., Meijer, D. K. F., Jansen, P. L. M., Kuipers, F., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70462-2 · Cited by 60
Gerloff, T., Geier, A., Roots, I., Meier, P. J., & Gartung, C. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03030.x · Cited by 58
Houten, S. M., & Auwerx, J. H. (2004) · Annals of Medicine · doi:10.1080/07853890410018790 · Cited by 54
Pall, H., Zielenski, J., Jonas, M. M., DaSilva, D. A., Potvin, K., Yuan, X.-W., Huang, Q., & Freedman, S. D. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.03.062 · Cited by 54
CYTOKINES AND THE PROGRESSION OF LIVER DAMAGE IN EXPERIMENTAL BILE DUCT LIGATION
Plebani, M., Panozzo, M. P., Basso, D., Paoli, M. D., Biasin, R., & Infantolino, D. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03042.x · Cited by 53
Wagner, M., & Trauner, M. (2005) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32071-x · Cited by 53
Self-citationThe Immunophysiology of Biliary Epithelium
Fava, G., Glaser, S. S., Francis, H., & Alpini, G. D. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-916318 · Cited by 49
Molecular basis of intrahepatic cholestasis
Carlton, V. E. H., Pawlikowska, L., & Bull, L. N. (2004) · Annals of Medicine · doi:10.1080/07853890410018916 · Cited by 47
The farnesoid X receptor: a novel drug target?
Claudel, T., Sturm, E., Kuipers, F., & Staels, B. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.9.1135 · Cited by 47
Henckaerts, L., Jaspers, M., Steenbergen, W. V., Vliegen, L., Fevery, J., Nuytten, H., Roskams, T., Rutgeerts, P. J., Cassiman, J., Vermeire, S., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.033 · Cited by 46
Öhlinger, W., Dinges, H. P., Zatloukal, K., Mair, S., Gollowitsch, F., & Denk, H. (1993) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf01614767 · Cited by 39
Medical Treatment of Cholestatic Liver Disease
Paumgartner, G., & Pusl, T. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2007.11.013 · Cited by 39
Ohishi, Y., Nakamura, M., Iio, N., Higa, S., Inayoshi, M., Aiba, Y., Komori, A., Omagari, K., Ishibashi, H., & Tsukamoto, K. (2008) · Hepatology · doi:10.1002/hep.22382 · Cited by 37
ABCB4 gene mutations and primary sclerosing cholangitis
Rosmorduc, O., Hermelin, B., Boëlle, P., Poupon, R. E., Poupon, R. Y., & Chazouillères, O. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.02.042 · Cited by 36
Bertolotti, M., Carulli, L., Concari, M., Martella, P., Loria, P., Tagliafico, E., Ferrari, S., Puppo, M. D., Amati, B., Fabiani, E. D., et al. (2001) · Hepatology · doi:10.1053/jhep.2001.25958 · Cited by 31
Effect of biliary obstruction on 26-hydroxylation of C27-steroids in bile acid synthesis
Gustafsson, J. (1978) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41563-9 · Cited by 31
Clinical Hepatotoxicity. Regulation and Treatment with Inducers of Transport and Cofactors
Marschall, H., Wagner, M., Zollner, G., & Trauner, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060133c · Cited by 30
Self-citationEndogenous interferon γ protects against cholestatic liver injury in mice
Sewnath, M. E., van der Poll, T., Noorden, C. J. F. V., ten Kate, F. J. W., & Gouma, D. J. (2002) · Hepatology · doi:10.1053/jhep.2002.37196 · Cited by 27
Fickert, P., & Trauner, M. A. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.006 · Cited by 13
Self-citation
Cited by
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935
“stasis (Wagner et al., 2009).”
Di Ciaula, A., Garruti, G., Lunardi Baccetto, R., Molina-Molina, E., Bonfrate, L., Wang, D. Q.-H., & Portincasa, P. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.5493 · Cited by 569
Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology
Fuchs, C. D., & Trauner, M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00566-7 · Cited by 490
Self-citationThe adverse outcome pathway concept: A pragmatic tool in toxicology
Vinken, M. (2013) · Toxicology · doi:10.1016/j.tox.2013.08.011 · Cited by 467
The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation
Pols, T. W. H., Noriega, L. G., Nomura, M., Auwerx, J., & Schoonjans, K. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.004 · Cited by 454
Metadata
- Authors
- Wagner, M., Zollner, G., & Trauner, M.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 51
- Issue
- 3
- Pages
- 565-580
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W1994912901
- Cited by
- 260
- References
- 186
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.